Edgar B. Cale - 15 Mar 2025 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Reporting relationship: GC & CORPORATE SECRETARY
Issuer ticker: PASG
Reported as of: 15 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Mar 2025, 17:11:05 UTC
Prior SEC filing: 02 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ William Chou, Attorney-in-Fact

Key filing fact

Edgar B. Cale filed Form 4 for Passage BIO, Inc. (PASG) on 18 Mar 2025.

Key facts

This page summarizes Edgar B. Cale's Form 4 filing for Passage BIO, Inc. (PASG).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Mar 2025, 17:11.

Change

Previous filing in this sequence was filed on 02 Oct 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PASG transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +278,386
Change %
Price: $0.000000
Shares after: 278,386
Date: 15 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 278,386
Exercise price: $0.3870
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests as to 1/48 of the total shares monthly beginning on April 15, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.